- Home
- LPCN vs TRIB Comparison
LPCN vs TRIB Comparison
Compare LPCN & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- TRIB
- Stock Information
- Founded
- LPCN 1997
- TRIB 1992
- Country
- LPCN United States
- TRIB Ireland
- Employees
- LPCN N/A
- TRIB N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- LPCN Health Care
- TRIB Health Care
- Exchange
- LPCN Nasdaq
- TRIB Nasdaq
- Market Cap
- LPCN 16.1M
- TRIB 14.0M
- IPO Year
- LPCN N/A
- TRIB N/A
- Fundamental
- Price
- LPCN $2.95
- TRIB $0.83
- Analyst Decision
- LPCN Strong Buy
- TRIB
- Analyst Count
- LPCN 2
- TRIB 0
- Target Price
- LPCN $9.00
- TRIB N/A
- AVG Volume (30 Days)
- LPCN 36.3K
- TRIB 207.2K
- Earning Date
- LPCN 08-05-2025
- TRIB 08-19-2025
- Dividend Yield
- LPCN N/A
- TRIB N/A
- EPS Growth
- LPCN N/A
- TRIB N/A
- EPS
- LPCN N/A
- TRIB N/A
- Revenue
- LPCN $4,208,119.00
- TRIB $61,555,000.00
- Revenue This Year
- LPCN N/A
- TRIB $13.51
- Revenue Next Year
- LPCN N/A
- TRIB $13.14
- P/E Ratio
- LPCN N/A
- TRIB N/A
- Revenue Growth
- LPCN N/A
- TRIB 8.31
- 52 Week Low
- LPCN $2.68
- TRIB $0.48
- 52 Week High
- LPCN $6.17
- TRIB $3.39
- Technical
- Relative Strength Index (RSI)
- LPCN 37.54
- TRIB 57.44
- Support Level
- LPCN $2.92
- TRIB $0.66
- Resistance Level
- LPCN $3.25
- TRIB $0.93
- Average True Range (ATR)
- LPCN 0.19
- TRIB 0.06
- MACD
- LPCN -0.04
- TRIB 0.02
- Stochastic Oscillator
- LPCN 4.41
- TRIB 66.69
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.